Ajanta Pharma News

Pls find enclosed Investor Call Intimation

Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 ,inter alia, to consider and approve Unaudited consolidated and standalone financial results for the second quarter and half year ended 30th September 2025

Please find enclosed herewith Sustainability Report for FY 2025, prepared in accordance with the Global Reporting Initiative (GRI) Standards.

Pls find enclosed herewith Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 03, 2025 for Aayush Agrawal, trustee Aayush Agrawal Trust

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 03, 2025 for Ravi Agrawal, trustee Ravi Agrawal Trust

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 25, 2025 for Ravi Agrawal, trustee Ravi Agrawal Trust

PFA Intimation w.r.t Closure of Trading Window

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 16, 2025 for Ravi Agrawal, trustee Ravi Agrawal Trust

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 10, 2025 for Ravi Agrawal, trustee Ravi Agrawal Trust

Pls find enclosed Newspaper Advertisement

Please find enclosed intimation w.r.t Participation in Investor Conference.

Along with semiconductors, electronics and IT, pharma is another sector exempt from the Trump tariffs. Still, as the broader indices declined after the imposition of two rounds of tariffs, with the latest of 25% kicking in on August 27, pharma stocks have also seen drops over the past month. Now, is this an opportunity, given that the sector is exempt? Perhaps. Because, one does not know what President Trump may do in the future. But the pharma sector merits a closer look for reasons other than being exempt from tariffs. For, in the last 20 years, companies in this sector, because of some inherent advantages, have been able to deliver. And going forward, there is a high probability that these tailwinds will increase.

Pls find enclosed Intimation under Regulation 30 of SEBI LODR Regulations 2015.

Pls find enclosed Written Transcript of Earnings Call held on 28th July 2025.

PFA newspaper publication of results for the quarter ended 30.06.2025.

PFA Audio Link of Investor Call.

PFA ESOP Allotment announcement

Outcome of the Board Meeting

PFA Unaudited Financial Results for quarter ended 30.06.2025.

The Nifty Pharma index closed 0.27 per cent down at 22531.85.

The Nifty Pharma index was trading 0.06 per cent down at 22578.95.

Pls find enclosed Voting Results pursuant to Regulation 44 of SEBI LODR Regulations and Scrutinizer''s Report

The Nifty Pharma index closed 0.38 per cent up at 22680.35.

Please find enclosed Proceedings of AGM pursuant to Regulation 30 of SEBI LODR Regulations, 2015.

PFA Investor Call Intimation.

Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 ,inter alia, to consider and approve Unaudited financial results for the quarter ended 30.06.2025.

The Nifty Pharma index was trading 0.28 per cent down at 22602.4.

The Nifty Pharma index was trading 0.35 per cent up at 22303.75.

The Nifty Pharma index closed 0.59 per cent down at 22076.8.

PFA Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 30.06.2025

All long-term investors know that corrections are part of every bull run. But, it is important to know whether they are caused by global or domestic factors. Why? Because the magnitude of the correction (price damage, how long it lasts) and how the recovery shapes up are different for those sparked by global and domestic events. But why speak of a correction when things are looking up? Because, in the stock market, it pays to be future ready. So, while being bullish, be ready for volatility. How? By picking the right sector and the market cap segment to buy from. And always make a distinction between news and noise.

The Nifty Pharma index closed 0.42 per cent up at 22204.25.

The Nifty Pharma index closed 0.32 per cent up at 22110.8.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 02, 2025 for Aayush Agrawal, trustee Aayush Agrawal Trust

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 30, 2025 for Ravi Agrawal, trustee Ravi Agrawal Trust

The Nifty Pharma index was trading 0.19 per cent up at 21969.5.

The Nifty Pharma index closed 0.02 per cent up at 21808.2.

PFA Intimation w.r.t Closure of Trading Window

Stock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company analyses, the report also collates analysts’ forecasts and trend analysis for each component. An average score in Stock Reports Plus is calculated by undertaking quantitative analysis of five key investment tools – earnings, fundamentals, relative valuation, risk, and price momentum.